Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.
about
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2Genome-Wide Association Study in Immunocompetent Patients with Delayed Hypersensitivity to Sulfonamide AntimicrobialsHLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.Integrating precision medicine in the study and clinical treatment of a severely mentally ill personThe involvement of mitochondrial amidoxime reducing components 1 and 2 and mitochondrial cytochrome b5 in N-reductive metabolism in human cells.RNA expression profiling in sulfamethoxazole-treated patients with a range of in vitro lymphocyte cytotoxicity phenotypes.
P2860
Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Evaluation of polymorphisms in ...... sulfonamide hypersensitivity.
@en
type
label
Evaluation of polymorphisms in ...... sulfonamide hypersensitivity.
@en
prefLabel
Evaluation of polymorphisms in ...... sulfonamide hypersensitivity.
@en
P2093
P2860
P50
P1476
Evaluation of polymorphisms in ...... sulfonamide hypersensitivity.
@en
P2093
Alison Motsinger-Reif
Lauren A Trepanier
Mahmoud Abouraya
Steven H Yale
P2860
P304
P356
10.1097/FPC.0B013E328357A735
P577
2012-10-01T00:00:00Z